Boehringer Ingelheim Corporation Sex Pill, Flibanserin May Not Aid Women, FDA Staff Say

Bloomberg -- Boehringer Ingelheim GmbH’s sexual desire drug flibanserin may not be effective or safe, according to U.S. regulators weighing whether to approve the first pill designed to boost women’s libidos.